Bal Pharma Limited (NSE:BALPHARMA)
India · Delayed Price · Currency is INR 85.00
+1.82 (2.19%)
Nov 11, 2026, 2:19 PM IST
Bal Pharma Market Cap
Bal Pharma has a market cap or net worth of 1.36 billion as of November 10, 2026. Its market cap has increased by 5.23% in one year.
Market Cap
1.36B
Enterprise Value
2.86B
Revenue
3.34B
Global Rank
n/a
Country Rank
n/a
PE Ratio
18.88
ChartMarket Cap Chart
Since December 20, 2004, Bal Pharma's market cap has increased from 559.95M to 1.36B, an increase of 142.35%. That is a compound annual growth rate of 4.12%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 11, 2026 | 1.36B | 16.36% |
| Dec 31, 2025 | 1.17B | -39.96% |
| Dec 31, 2024 | 1.94B | 23.18% |
| Dec 29, 2023 | 1.58B | 10.20% |
| Dec 30, 2022 | 1.43B | -8.67% |
| Dec 31, 2021 | 1.57B | 96.53% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sigachi Industries | 10.52B |
| Amanta Healthcare | 7.85B |
| Valiant Laboratories | 5.94B |
| Nectar Lifesciences | 2.02B |
| Brooks Laboratories | 1.98B |
| Par Drugs and Chemicals | 1.46B |
| Balaxi Pharmaceuticals | 1.26B |
| Alpa Laboratories | 1.21B |